Sunclouds, The 342 should be 390 according to t
Post# of 148174
(Total Views: 490)
Posted On: 04/07/2020 7:36:39 PM
Sunclouds,
There was nothing wrong and NP explained it: The FDA has 30 days to make comments on the trial proposal. They said that 390 would be better.
CYDY then changed the trial proposal.
Where is the "wrong" number (there wasn't a right number, there was a proposed number) ??? . Please do the required DD before you post.
BTW, the primary end point has changed as well !!! Now is 4 weeks survival. 2 Weeks is secondary now.
Quote:
The 342 should be 390 according to the proactive investors video.
The new primary endpoint is properly listed but the patients are wrong.
There was nothing wrong and NP explained it: The FDA has 30 days to make comments on the trial proposal. They said that 390 would be better.
CYDY then changed the trial proposal.
Where is the "wrong" number (there wasn't a right number, there was a proposed number) ??? . Please do the required DD before you post.
BTW, the primary end point has changed as well !!! Now is 4 weeks survival. 2 Weeks is secondary now.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼